(Q30383709)

21 June 2017

1 reference

title

Pandemic influenza A (H1N1) 2009: the experience of the first six months. (English)

1 reference

21 June 2017

0 references

Jean Maritz

1

1 reference

21 June 2017

Leana Maree

series ordinal

2

1 reference

21 June 2017

Wolfgang Preiser

series ordinal

3

1 reference

21 June 2017

publication date

1 January 2010

1 reference

Clinical Chemistry and Laboratory Medicine

21 June 2017

published in

1 reference

21 June 2017

volume

48

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

11-21

1 reference

Emergence of influenza A viruses

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Emergence and pandemic potential of swine-origin H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Strategies for containing an emerging influenza pandemic in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Strategies for mitigating an influenza pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

H1N1 2009 influenza virus infection during pregnancy in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Pandemic H1N1 infection in pregnant women in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Obesity is associated with increased morbidity but not mortality in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Novel human parechovirus from Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Response to a monovalent 2009 influenza A (H1N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Effectiveness of maternal influenza immunization in mothers and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Viral zoonoses - a threat under control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.023

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.023

1 reference

21 June 2017

1 reference